Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome

Tim Flerlage1,2, Jeremy Chase Crawford3, E Kaitlynn Allen3

  • 1Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Nature Communications
|June 30, 2023
PubMed

Insights

Pediatric ARDS involves immune responses. This study found reduced interferon gene expression and altered immune cell programs in severe cases, suggesting new therapeutic targets for acute respiratory failure in infants.

Area of Science:

  • Pediatric critical care medicine
  • Immunology
  • Genomics

Background:

  • Acute respiratory distress syndrome (ARDS) in children, or pediatric ARDS (pARDS), is a severe condition linked to abnormal immune responses.
  • Understanding the immune mechanisms in pARDS is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate microbial and host gene expression profiles in tracheal aspirates from infants with acute respiratory failure.
  • To identify immune signatures associated with the severity of pediatric ARDS.

Main Methods:

  • Longitudinal collection of tracheal aspirates from infants with acute respiratory failure.
  • Microbial sequencing and single-cell gene expression analysis.
  • Comparison of transcriptional profiles between moderate-to-severe pARDS and mild/no pARDS groups.

Main Results:

  • Reduced interferon-stimulated gene (ISG) expression was observed in moderate to severe pARDS.
  • Altered transcriptional programs in mononuclear phagocytes (MNPs) and progressive airway neutrophilia were identified.
  • Folate Receptor 3 (FOLR3), an innate immune cell product, was enriched in moderate to severe pARDS.
  • Distinct inflammatory profiles correlated with pARDS etiology and severity, particularly in RSV-induced cases.

Conclusions:

  • Reduced ISG expression, altered macrophage repair programs, and aged neutrophil accumulation are implicated in moderate to severe pARDS pathogenesis.
  • Immune responses in pARDS are diverse and depend on the cause and severity.
  • Findings highlight potential biomarkers and therapeutic targets for pARDS.